Global Drug Transport Technology

Drug Transport Technology Comprehensive Study by Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Application (Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers, Others), Technology (Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Others), Device (Ambulatory infusion pumps, Valves, Needles, Paediatric IV set, Others) Players and Region - Global Market Outlook to 2030

Drug Transport Technology Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Drug Transport Technology
Drug transport technology is used to transport medicine to an exact location in the body in the case of cancer, tumor etc. Drug transport technology market is expected to mark significant growth over forecasted period owing to increasing prevalence of chronic diseases, availability of advanced technology and continuous launch of new products. For Instance, Sun Pharma launched a product which is related to novel drug that beneficial for heart patients in US market. Further, increasing demand for the drug transport technology expected to drive the market growth over the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The market is highly fragmented with the presence of various players in the market. Some of the key strategies followed by the players operating in the market were innovation, product development, acquisition, and expansion. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Johnson & Johnson, Inc. (United States), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. United States), Bayer AG (Germany), Pfizer, Inc. (United States), Novartis AG (Switzerland), 3M Company (United States), Becton, Dickinson, and Company (United States), GlaxoSmithKline plc, (United Kingdom), Sanofi (France) and Antares Pharma, Inc. (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Drug Transport Technology market by Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery and Implantable Drug Delivery), Application (Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers and Others) and Region.



On the basis of geography, the market of Drug Transport Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Prodrug will boost the Drug Transport Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Device, the sub-segment i.e. Ambulatory infusion pumps will boost the Drug Transport Technology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in Research and Developments Activities Leads to Boost the Market and Rise in Demand of Drug Transport Technology in Emerging Countries.

Market Growth Drivers:
Increase Prevalence Of Diseases Boost the Drug Transport Technology Market and Rising Aging Population Fuelled up the Drug Transport Technology Market

Challenges:
Limitation Due to Product Recall are Anticipated to Challenge the Market. and Substitutes Available Such as Nano Medicine-Based Drug Transport Threat the Drug Transport Technology Market

Restraints:
Lack of Skilled and Trained Professional Hampers the Drug Transport Technology Market and Dosage Error Leads to Restrain the Market

Opportunities:
Proliferation of Technology Advancements Such as Sigma Spectrum Infusion System Leads to Grow the Drug Transport Technology Market and Upsurge Demand of Novel Drug Transport Technology Expected to Boost the Market

Market Leaders and their expansionary development strategies
In January 2023 – BioNTech SE and InstaDeep Ltd. announced that they have entered into an agreement under which BioNTech will acquire InstaDeep, a leading global technology company in the field of artificial intelligence (“AI”) and machine learning (“ML”). Acquisition to enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging artificial intelligence and machine learning technologies across BioNTech’s therapeutic platforms and operations
In March 2024, bioXcelerate, a new and innovative health data science division of Optima Partners Limited, has revealed a new groundbreaking AI tool, which is set to accelerate the process for identifying and developing new drugs. The tool, known as PleioGraph, can analyze complex medical data 100 times faster than existing state-of-the-art methods used to detect biological networks which explain disease risk and inform drug discovery.
“According to Pharmaceutical Regulatory Affairs, its act as an important role for approval of generics and the process is also being very stringent in various countries such as United States, Europe, Canada, Australia, and Japan includes standard skin irritation, sensitization and adhesion studies with the patch itself in animals/humans. The production of transdermal drug delivery system medications has increased, because these sorts of systems have proved more effective in many situations at directly sending drugs into the body.”

Key Target Audience
Drug Delivery System Manufacturers, Drug Delivery System Traders, End-Use Market Participants of Different Segments of Drug Delivery System, Government and Research Organizations, R&D Institutions and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Pulmonary Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
By Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care settings
  • Diagnostic Centers
  • Others
By Technology
  • Prodrug
  • Implants And Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Others

By Device
  • Ambulatory infusion pumps
  • Valves
  • Needles
  • Paediatric IV set
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase Prevalence Of Diseases Boost the Drug Transport Technology Market
      • 3.2.2. Rising Aging Population Fuelled up the Drug Transport Technology Market
    • 3.3. Market Challenges
      • 3.3.1. Limitation Due to Product Recall are Anticipated to Challenge the Market.
      • 3.3.2. Substitutes Available Such as Nano Medicine-Based Drug Transport Threat the Drug Transport Technology Market
    • 3.4. Market Trends
      • 3.4.1. Increase in Research and Developments Activities Leads to Boost the Market
      • 3.4.2. Rise in Demand of Drug Transport Technology in Emerging Countries.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Transport Technology, by Type, Application, Technology, Device and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Drug Transport Technology (Value)
      • 5.2.1. Global Drug Transport Technology by: Type (Value)
        • 5.2.1.1. Oral Drug Delivery
        • 5.2.1.2. Injectable Drug Delivery
        • 5.2.1.3. Topical Drug Delivery
        • 5.2.1.4. Pulmonary Drug Delivery
        • 5.2.1.5. Ocular Drug Delivery
        • 5.2.1.6. Nasal Drug Delivery
        • 5.2.1.7. Transmucosal Drug Delivery
        • 5.2.1.8. Implantable Drug Delivery
      • 5.2.2. Global Drug Transport Technology by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
        • 5.2.2.3. Home Care settings
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Others
      • 5.2.3. Global Drug Transport Technology by: Technology (Value)
        • 5.2.3.1. Prodrug
        • 5.2.3.2. Implants And Intrauterine Devices
        • 5.2.3.3. Targeted Drug Delivery
        • 5.2.3.4. Polymeric Drug Delivery
        • 5.2.3.5. Others
      • 5.2.4. Global Drug Transport Technology by: Device (Value)
        • 5.2.4.1. Ambulatory infusion pumps
        • 5.2.4.2. Valves
        • 5.2.4.3. Needles
        • 5.2.4.4. Paediatric IV set
        • 5.2.4.5. Others
      • 5.2.5. Global Drug Transport Technology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Drug Transport Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. F. Hoffman-La Roche (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck & Co., Inc. United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. 3M Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Becton, Dickinson, and Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline plc, (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sanofi (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Antares Pharma, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Drug Transport Technology Sale, by Type, Application, Technology, Device and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Drug Transport Technology (Value)
      • 7.2.1. Global Drug Transport Technology by: Type (Value)
        • 7.2.1.1. Oral Drug Delivery
        • 7.2.1.2. Injectable Drug Delivery
        • 7.2.1.3. Topical Drug Delivery
        • 7.2.1.4. Pulmonary Drug Delivery
        • 7.2.1.5. Ocular Drug Delivery
        • 7.2.1.6. Nasal Drug Delivery
        • 7.2.1.7. Transmucosal Drug Delivery
        • 7.2.1.8. Implantable Drug Delivery
      • 7.2.2. Global Drug Transport Technology by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
        • 7.2.2.3. Home Care settings
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Others
      • 7.2.3. Global Drug Transport Technology by: Technology (Value)
        • 7.2.3.1. Prodrug
        • 7.2.3.2. Implants And Intrauterine Devices
        • 7.2.3.3. Targeted Drug Delivery
        • 7.2.3.4. Polymeric Drug Delivery
        • 7.2.3.5. Others
      • 7.2.4. Global Drug Transport Technology by: Device (Value)
        • 7.2.4.1. Ambulatory infusion pumps
        • 7.2.4.2. Valves
        • 7.2.4.3. Needles
        • 7.2.4.4. Paediatric IV set
        • 7.2.4.5. Others
      • 7.2.5. Global Drug Transport Technology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Transport Technology: by Type(USD Million)
  • Table 2. Drug Transport Technology Oral Drug Delivery , by Region USD Million (2018-2023)
  • Table 3. Drug Transport Technology Injectable Drug Delivery , by Region USD Million (2018-2023)
  • Table 4. Drug Transport Technology Topical Drug Delivery , by Region USD Million (2018-2023)
  • Table 5. Drug Transport Technology Pulmonary Drug Delivery , by Region USD Million (2018-2023)
  • Table 6. Drug Transport Technology Ocular Drug Delivery , by Region USD Million (2018-2023)
  • Table 7. Drug Transport Technology Nasal Drug Delivery , by Region USD Million (2018-2023)
  • Table 8. Drug Transport Technology Transmucosal Drug Delivery , by Region USD Million (2018-2023)
  • Table 9. Drug Transport Technology Implantable Drug Delivery , by Region USD Million (2018-2023)
  • Table 10. Drug Transport Technology: by Application(USD Million)
  • Table 11. Drug Transport Technology Hospitals , by Region USD Million (2018-2023)
  • Table 12. Drug Transport Technology Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 13. Drug Transport Technology Home Care settings , by Region USD Million (2018-2023)
  • Table 14. Drug Transport Technology Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 15. Drug Transport Technology Others , by Region USD Million (2018-2023)
  • Table 16. Drug Transport Technology: by Technology(USD Million)
  • Table 17. Drug Transport Technology Prodrug , by Region USD Million (2018-2023)
  • Table 18. Drug Transport Technology Implants And Intrauterine Devices , by Region USD Million (2018-2023)
  • Table 19. Drug Transport Technology Targeted Drug Delivery , by Region USD Million (2018-2023)
  • Table 20. Drug Transport Technology Polymeric Drug Delivery , by Region USD Million (2018-2023)
  • Table 21. Drug Transport Technology Others , by Region USD Million (2018-2023)
  • Table 22. Drug Transport Technology: by Device(USD Million)
  • Table 23. Drug Transport Technology Ambulatory infusion pumps , by Region USD Million (2018-2023)
  • Table 24. Drug Transport Technology Valves , by Region USD Million (2018-2023)
  • Table 25. Drug Transport Technology Needles , by Region USD Million (2018-2023)
  • Table 26. Drug Transport Technology Paediatric IV set , by Region USD Million (2018-2023)
  • Table 27. Drug Transport Technology Others , by Region USD Million (2018-2023)
  • Table 28. South America Drug Transport Technology, by Country USD Million (2018-2023)
  • Table 29. South America Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 30. South America Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 31. South America Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 32. South America Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 33. Brazil Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 34. Brazil Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 35. Brazil Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 36. Brazil Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 37. Argentina Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 38. Argentina Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 39. Argentina Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 40. Argentina Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 41. Rest of South America Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 42. Rest of South America Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 43. Rest of South America Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 44. Rest of South America Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 45. Asia Pacific Drug Transport Technology, by Country USD Million (2018-2023)
  • Table 46. Asia Pacific Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 47. Asia Pacific Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 48. Asia Pacific Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 49. Asia Pacific Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 50. China Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 51. China Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 52. China Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 53. China Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 54. Japan Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 55. Japan Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 56. Japan Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 57. Japan Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 58. India Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 59. India Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 60. India Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 61. India Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 62. South Korea Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 63. South Korea Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 64. South Korea Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 65. South Korea Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 66. Taiwan Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 67. Taiwan Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 68. Taiwan Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 69. Taiwan Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 70. Australia Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 71. Australia Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 72. Australia Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 73. Australia Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 75. Rest of Asia-Pacific Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 76. Rest of Asia-Pacific Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 77. Rest of Asia-Pacific Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 78. Europe Drug Transport Technology, by Country USD Million (2018-2023)
  • Table 79. Europe Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 80. Europe Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 81. Europe Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 82. Europe Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 83. Germany Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 84. Germany Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 85. Germany Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 86. Germany Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 87. France Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 88. France Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 89. France Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 90. France Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 91. Italy Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 92. Italy Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 93. Italy Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 94. Italy Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 95. United Kingdom Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 96. United Kingdom Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 97. United Kingdom Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 98. United Kingdom Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 99. Netherlands Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 100. Netherlands Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 101. Netherlands Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 102. Netherlands Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 103. Rest of Europe Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 104. Rest of Europe Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 105. Rest of Europe Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 106. Rest of Europe Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 107. MEA Drug Transport Technology, by Country USD Million (2018-2023)
  • Table 108. MEA Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 109. MEA Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 110. MEA Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 111. MEA Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 112. Middle East Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 113. Middle East Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 114. Middle East Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 115. Middle East Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 116. Africa Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 117. Africa Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 118. Africa Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 119. Africa Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 120. North America Drug Transport Technology, by Country USD Million (2018-2023)
  • Table 121. North America Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 122. North America Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 123. North America Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 124. North America Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 125. United States Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 126. United States Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 127. United States Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 128. United States Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 129. Canada Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 130. Canada Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 131. Canada Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 132. Canada Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 133. Mexico Drug Transport Technology, by Type USD Million (2018-2023)
  • Table 134. Mexico Drug Transport Technology, by Application USD Million (2018-2023)
  • Table 135. Mexico Drug Transport Technology, by Technology USD Million (2018-2023)
  • Table 136. Mexico Drug Transport Technology, by Device USD Million (2018-2023)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Drug Transport Technology: by Type(USD Million)
  • Table 149. Drug Transport Technology Oral Drug Delivery , by Region USD Million (2025-2030)
  • Table 150. Drug Transport Technology Injectable Drug Delivery , by Region USD Million (2025-2030)
  • Table 151. Drug Transport Technology Topical Drug Delivery , by Region USD Million (2025-2030)
  • Table 152. Drug Transport Technology Pulmonary Drug Delivery , by Region USD Million (2025-2030)
  • Table 153. Drug Transport Technology Ocular Drug Delivery , by Region USD Million (2025-2030)
  • Table 154. Drug Transport Technology Nasal Drug Delivery , by Region USD Million (2025-2030)
  • Table 155. Drug Transport Technology Transmucosal Drug Delivery , by Region USD Million (2025-2030)
  • Table 156. Drug Transport Technology Implantable Drug Delivery , by Region USD Million (2025-2030)
  • Table 157. Drug Transport Technology: by Application(USD Million)
  • Table 158. Drug Transport Technology Hospitals , by Region USD Million (2025-2030)
  • Table 159. Drug Transport Technology Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 160. Drug Transport Technology Home Care settings , by Region USD Million (2025-2030)
  • Table 161. Drug Transport Technology Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 162. Drug Transport Technology Others , by Region USD Million (2025-2030)
  • Table 163. Drug Transport Technology: by Technology(USD Million)
  • Table 164. Drug Transport Technology Prodrug , by Region USD Million (2025-2030)
  • Table 165. Drug Transport Technology Implants And Intrauterine Devices , by Region USD Million (2025-2030)
  • Table 166. Drug Transport Technology Targeted Drug Delivery , by Region USD Million (2025-2030)
  • Table 167. Drug Transport Technology Polymeric Drug Delivery , by Region USD Million (2025-2030)
  • Table 168. Drug Transport Technology Others , by Region USD Million (2025-2030)
  • Table 169. Drug Transport Technology: by Device(USD Million)
  • Table 170. Drug Transport Technology Ambulatory infusion pumps , by Region USD Million (2025-2030)
  • Table 171. Drug Transport Technology Valves , by Region USD Million (2025-2030)
  • Table 172. Drug Transport Technology Needles , by Region USD Million (2025-2030)
  • Table 173. Drug Transport Technology Paediatric IV set , by Region USD Million (2025-2030)
  • Table 174. Drug Transport Technology Others , by Region USD Million (2025-2030)
  • Table 175. South America Drug Transport Technology, by Country USD Million (2025-2030)
  • Table 176. South America Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 177. South America Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 178. South America Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 179. South America Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 180. Brazil Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 181. Brazil Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 182. Brazil Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 183. Brazil Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 184. Argentina Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 185. Argentina Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 186. Argentina Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 187. Argentina Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 188. Rest of South America Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 189. Rest of South America Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 190. Rest of South America Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 191. Rest of South America Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 192. Asia Pacific Drug Transport Technology, by Country USD Million (2025-2030)
  • Table 193. Asia Pacific Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 194. Asia Pacific Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 195. Asia Pacific Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 196. Asia Pacific Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 197. China Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 198. China Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 199. China Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 200. China Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 201. Japan Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 202. Japan Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 203. Japan Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 204. Japan Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 205. India Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 206. India Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 207. India Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 208. India Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 209. South Korea Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 210. South Korea Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 211. South Korea Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 212. South Korea Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 213. Taiwan Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 214. Taiwan Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 215. Taiwan Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 216. Taiwan Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 217. Australia Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 218. Australia Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 219. Australia Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 220. Australia Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 221. Rest of Asia-Pacific Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 222. Rest of Asia-Pacific Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 223. Rest of Asia-Pacific Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 224. Rest of Asia-Pacific Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 225. Europe Drug Transport Technology, by Country USD Million (2025-2030)
  • Table 226. Europe Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 227. Europe Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 228. Europe Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 229. Europe Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 230. Germany Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 231. Germany Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 232. Germany Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 233. Germany Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 234. France Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 235. France Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 236. France Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 237. France Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 238. Italy Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 239. Italy Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 240. Italy Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 241. Italy Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 242. United Kingdom Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 243. United Kingdom Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 244. United Kingdom Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 245. United Kingdom Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 246. Netherlands Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 247. Netherlands Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 248. Netherlands Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 249. Netherlands Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 250. Rest of Europe Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 251. Rest of Europe Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 252. Rest of Europe Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 253. Rest of Europe Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 254. MEA Drug Transport Technology, by Country USD Million (2025-2030)
  • Table 255. MEA Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 256. MEA Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 257. MEA Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 258. MEA Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 259. Middle East Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 260. Middle East Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 261. Middle East Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 262. Middle East Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 263. Africa Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 264. Africa Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 265. Africa Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 266. Africa Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 267. North America Drug Transport Technology, by Country USD Million (2025-2030)
  • Table 268. North America Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 269. North America Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 270. North America Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 271. North America Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 272. United States Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 273. United States Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 274. United States Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 275. United States Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 276. Canada Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 277. Canada Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 278. Canada Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 279. Canada Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 280. Mexico Drug Transport Technology, by Type USD Million (2025-2030)
  • Table 281. Mexico Drug Transport Technology, by Application USD Million (2025-2030)
  • Table 282. Mexico Drug Transport Technology, by Technology USD Million (2025-2030)
  • Table 283. Mexico Drug Transport Technology, by Device USD Million (2025-2030)
  • Table 284. Research Programs/Design for This Report
  • Table 285. Key Data Information from Secondary Sources
  • Table 286. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Transport Technology: by Type USD Million (2018-2023)
  • Figure 5. Global Drug Transport Technology: by Application USD Million (2018-2023)
  • Figure 6. Global Drug Transport Technology: by Technology USD Million (2018-2023)
  • Figure 7. Global Drug Transport Technology: by Device USD Million (2018-2023)
  • Figure 8. South America Drug Transport Technology Share (%), by Country
  • Figure 9. Asia Pacific Drug Transport Technology Share (%), by Country
  • Figure 10. Europe Drug Transport Technology Share (%), by Country
  • Figure 11. MEA Drug Transport Technology Share (%), by Country
  • Figure 12. North America Drug Transport Technology Share (%), by Country
  • Figure 13. Global Drug Transport Technology share by Players 2023 (%)
  • Figure 14. Global Drug Transport Technology share by Players (Top 3) 2023(%)
  • Figure 15. Global Drug Transport Technology share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. F. Hoffman-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 20. F. Hoffman-La Roche (Switzerland) Revenue: by Geography 2023
  • Figure 21. Merck & Co., Inc. United States) Revenue, Net Income and Gross profit
  • Figure 22. Merck & Co., Inc. United States) Revenue: by Geography 2023
  • Figure 23. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 25. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 29. 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. 3M Company (United States) Revenue: by Geography 2023
  • Figure 31. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 33. GlaxoSmithKline plc, (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline plc, (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 36. Sanofi (France) Revenue: by Geography 2023
  • Figure 37. Antares Pharma, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Antares Pharma, Inc. (United States) Revenue: by Geography 2023
  • Figure 39. Global Drug Transport Technology: by Type USD Million (2025-2030)
  • Figure 40. Global Drug Transport Technology: by Application USD Million (2025-2030)
  • Figure 41. Global Drug Transport Technology: by Technology USD Million (2025-2030)
  • Figure 42. Global Drug Transport Technology: by Device USD Million (2025-2030)
  • Figure 43. South America Drug Transport Technology Share (%), by Country
  • Figure 44. Asia Pacific Drug Transport Technology Share (%), by Country
  • Figure 45. Europe Drug Transport Technology Share (%), by Country
  • Figure 46. MEA Drug Transport Technology Share (%), by Country
  • Figure 47. North America Drug Transport Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson, Inc. (United States)
  • F. Hoffman-La Roche (Switzerland)
  • Merck & Co., Inc. United States)
  • Bayer AG (Germany)
  • Pfizer, Inc. (United States)
  • Novartis AG (Switzerland)
  • 3M Company (United States)
  • Becton, Dickinson, and Company (United States)
  • GlaxoSmithKline plc, (United Kingdom)
  • Sanofi (France)
  • Antares Pharma, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 244 Pages 73 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Drug Transport Technology Quantitative research analysis
Global Drug Transport Technology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Johnson & Johnson, Inc. (United States), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. United States), Bayer AG (Germany), Pfizer, Inc. (United States), Novartis AG (Switzerland), 3M Company (United States), Becton, Dickinson, and Company (United States), GlaxoSmithKline plc, (United Kingdom), Sanofi (France) and Antares Pharma, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase in Research and Developments Activities Leads to Boost the Market " is seen as one of major influencing trends for Drug Transport Technology Market during projected period 2023-2030.
The Drug Transport Technology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Drug Transport Technology Report?

Have a Query? Click Here

Other Related Reports

IVF Services Comprehensive Study by Procedure (Intracytoplasmic Sperm Injection (ICSI-IVF), Non- ICSI-IVF, Intrauterine Insemination), Offering (IVF drugs, IVF media, Reagents, Other), Cycle Type (Fr...
$ 3750
Dental Insurance Services Comprehensive Study by Type (Dental Preferred Provider Organizations (DPPO), Dental Health Maintenance Organizations (DHMO), Dental Indemnity Plans, Others), Application (In...
$ 3650
Neurosyphilis Comprehensive Study by Type (Asymptomatic Neurosyphilis, Meningeal Neurosyphilis, Meningovascular Neurosyphilis, General Paresis, Tabes Dorsalis), Application (Hospital, Clinics, Others...
$ 3800
Cosmetic Dentistry Comprehensive Study by Type (Teeth Whitening, Dental Veneers, Dental Bonding, Dental Implants, Dental Crowns, Inlays & Onlays, Others), Application (Hospitals, Cosmetic Centers, De...
$ 3350
Emergency Telemedicine Services Comprehensive Study by Type (Tele-consultation, Tele-monitoring, Tele-education, Tele-care, Tele-training, Tele-surgery), Disease (Cardiology, Dermatology, Neurology, ...
$ 3800
Nasal Dressing Comprehensive Study by Type (Bioresorbable, Not Absorbable), Application (General Surgery, Otorhinolaryngology, Chronic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Hom...
$ 3350